Repligen (United States)
Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Repligen (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
42%
Total
Publications
204
Total Open
Publications
85
Total
Citations
7.3K
Open Access
Percentage
42%
Total
Publications
204
Total Open
Publications
85
Total
Citations
7.3K
Breakdown
Publisher Open
12%
Both
18%
Other Platform Open
7%
Closed
63%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
20
Hybrid 25%
14
No Guarantees 40%
23
Other Platform Open
Domain 80%
40
Other Internet 24%
12
Public 10%
5
Institution 4%
2
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 40 |
DOI | Other Internet | 10 |
Figshare | Public | 5 |
Europe PMC | Domain | 3 |
Unknown Repository | Other Internet | 2 |
Université Libre de Bruxelles - Dépôt institutionnel de l'Université libre de Bruxelles | Institution | 1 |
DASH - Digital Access to Scholarship at Harvard | Institution | 1 |
DANS - Data Archiving and Networked Services | Institution | 1 |